Idorsia Urges DEA to De-schedule DORA Class of Insomnia Drugs

Idorsia is asking the DEA to de-schedule the DORA class of chronic insomnia medications based on their low potential for abuse.

Related Keywords

United States ,Jean Paul Clozel ,Vaughn Mccall ,Idorsia Pharmaceuticals ,Augusta University ,Drug Enforcement Administration ,Drug Administration ,Drug Administration Adverse Events Reporting System ,Citizen Petition ,Controlled Substances ,Controlled Substances Act ,Adverse Events Reporting System ,Eight Factors ,Controlled Substance ,